Trade-offs between the benefits and risks of drug treatment for psoriasis: A discrete choice experiment with U.K. dermatologists

British Journal of Dermatology

Volumn 155, Issue 6, 2006, Pages 1236-1241

  Ashcroft, D M ^a   Seston, E ^a   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Discrete choice experiment; Drug treatment; Psoriasis; Risk benefit assessment

Indexed keywords

ANTIPSORIASIS AGENT;

ARTICLE; ATTRIBUTABLE RISK; DERMATOLOGY; DRUG EFFICACY; DRUG INFORMATION; DRUG PREFERENCE; DRUG USE; HUMAN; HYPERTENSION; LIVER INJURY; MEDICAL ASSESSMENT; POSTAL MAIL; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; RELAPSE; RISK BENEFIT ANALYSIS; SKIN CANCER; SKIN IRRITATION; TREATMENT RESPONSE;

ADULT; CHOICE BEHAVIOR; DERMATOLOGIC AGENTS; DERMATOLOGY; FEMALE; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 33750908270     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07535.x     Document Type: Article

References (23)

1. Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135:533-7.
2. Gelfand JM, Weinstein R, Porter SB et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141:1537-41.
3. Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137:280-4.
4. Montgomery AA, Fahey T. How do patients' treatment preferences compare with those of clinicians? Qual Health Care 2001; 10:i39-43.
5. Zug KA, Littenberg B, Baughman RD et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol 1995; 131:561-8.
6. Nijsten T, Margolis DJ, Feldman SR et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005; 52:434-44.
7. Griffiths CEM, Clark CM, Chalmers RJ et al. A systematic review of treatments for severe psoriasis. Health Technol Assess 2000; 4:1-125.
8. Ashcroft DM, Li W, Po A, Williams HC et al. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ 2000; 320:963-7.
9. Ho VC, Griffiths CEM, Albrecht G et al. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol 1999; 141:283-91.
10. Van Dooren-Greebe RJ, Kuijpers AL, Mulder J et al. Methotrexate revisited: effects of long-term treatment in psoriasis. Br J Dermatol 1994; 130:204-10.
11. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 2001; 358:1042-5.
12. Street DJ, Burgess L, Louviere JJ. Quick and easy choice sets: constructing optimal and nearly optimal stated choice experiments. Int J Res Mark 2005; 22:459-70.
13. Burgess L, Street D, Viney R et al. Design of choice experiments in health economics. In: The Elgar Companion to Health Economics (Jones A, ed), Gloucester: Edward Elgar Publishing, 2006; 415-27.
14. Greene WH. Models for discrete choice. Econometric Analysis, 5th edn. New Jersey: Prentice Hall, 2003; 663-755.
15. Small KA, Rosen HS. Applied welfare economics with discrete choice models. Econometrica 1981; 49:105-30.
16. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall, 1993.
17. Scott A. Identifying and analysing dominant preferences in discrete choice experiments: an application in health care. J Econ Psychol 2002; 23:383-98.
18. Strauss A, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Newbury Park, CA: Sage, 1990.
19. Fairhurst DA, Ashcroft DM, Griffiths CEM. Optimal management of severe plaque form of psoriasis. Am J Clin Dermatol 2005; 6:283-94.
20. Richards HL, Fortune DG, O'Sullivan TM et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41:581-3.
21. Slevin ML, Stubbs L, Plant HJ et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990; 300:1458-60.
22. Steel N. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ 2000; 320:1446-7.
23. McAlister FA, O'Connor AM, Wells G et al. When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ 2000; 163:403-8.